Analyst stock forecast
Caris Life Sciences Forecast: $28.15 Analyst Target
Direct answer
Caris Life Sciences's average price target is $28.15.
The target implies -10.8% from the recorded current price, and the consensus rating is Buy.
The low target implies -30.3%, the high target implies +14.1%, and the range spans 44.4% of the current price.
Forecast evidence checked September 30, 2026.
Get free Caris Life Sciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $31.55
- Average price target
- $28.15
- High price target
- $36.00
- Low price target
- $22.00
- Low target gap
- -30.3%
- Target upside
- -10.8%
- High target gap
- +14.1%
- Target range width
- 44.4%
- Consensus rating
- Buy
- Analysts
- 13
- Evidence date
- September 30, 2026
- Valid through
- October 7, 2026
Explore related company data
Read the frequently asked questions.
What is Caris Life Sciences's average price target?
Caris Life Sciences's verified average price target is $28.15. The target range is $22.00 to $36.00.
How far are Caris Life Sciences's low and high targets from the recorded price?
The low target implies -30.3%, while the high target implies +14.1%.
How many analysts are included in Caris Life Sciences's consensus?
The verified consensus includes 13 analysts.
How is Caris Life Sciences's target upside or downside calculated?
The average target of $28.15 is divided by the recorded price of $31.55, then one is subtracted to produce -10.8%. This does not guarantee a future return.
When was Caris Life Sciences's analyst forecast verified?
The data was verified on 2026-09-30. The dataset is valid through 2026-10-07.